A breakthrough in ATEX Zone 0 velocity sensing

Water monitoring

A breakthrough in ATEX Zone 0 velocity sensing

19 Nov, 2025

Mainstream Measurements Ltd has launched of MainProbeX, a next-generation ultrasonic velocity sensor engineered for high-risk, high-demand flow monitoring applications.

Combining ATEX Zone 0 certification with exceptional measurement precision, MainProbeX is set to redefine performance standards across the water, wastewater and industrial sectors.

MainProbeX performs a range of important functions: ATEX Zone 0 certification for safe operation in explosive atmospheres; high-accuracy ultrasonic velocity measurement in challenging hydraulic conditions; ultra-low power performance ideal for long-term remote deployments; ModBus RTU (RS-485) connectivity for seamless integration; and built-in intelligent diagnostics for fast, reliable installation.

Powered by the Mainstream Adaptive Measurement System (MAMS), MainProbeX continuously optimises energy use and signal quality, ensuring dependable, stable data even in demanding environments. It is designed to give utilities, engineers, and monitoring providers complete confidence in their flow data, without sacrificing battery life or installation time.

“MainProbeX is the result of precision engineering and decades of industry expertise,” says Managing Director Bev Bruce. “It represents a major step forward in hazardous-area velocity sensing and gives our customers the reliability they need for the next generation of monitoring challenges.”

The future of precision velocity measurement is here.

Latest News

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Lymph node behaviour may explain why brain tumours resist immunotherapy
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Next-generation analytical instrumentation delivers enhanced performance and usability
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow